SUPN Supernus Pharmaceuticals

Watchlist

32.060
+0.300+0.94%

Close Feb 28 16:00 ET

32.060
0.0000.00%

Post 20:01 ET

1.79BMarket Cap24.29P/E (TTM)

About Supernus Pharmaceuticals Company

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Company Profile

SymbolSUPN

Company NameSupernus Pharmaceuticals

Listing DateMay 1, 2012

Issue Price5.00

Founded2005

CEOMr. Jack A. Khattar

MarketNASDAQ

Employees674

Fiscal Year Ends12-31

Address9715 Key West Avenue

CityRockville

ProvinceMaryland

CountryUnited States of America

Zip Code20850

Phone1-301-838-2500

Websitehttp://www.supernus.com

Company Executives

Name
Position
Salary

Jack A. Khattar
Director, President, Chief Executive Officer and Secretary
13.28M

Padmanabh P. Bhatt
Senior Vice President, Intellectual Property and Chief Scientific Officer
1.47M

Dr. Jonathan Rubin, M.B.A.,M.D.
Senior Vice President, Research and Development and Chief Medical Officer
1.59M

Timothy C. Dec
Senior Vice President, Principal Accounting Officer and Chief Financial Officer
2.38M

Frank Mottola
Senior Vice President, Quality, GMP Operations and Information Technology
1.79M

Dr. Roman Bradel, PhD
Vice President, Regulatory Affairs
--

Charles W. Newhall, III
Chairman of the Board
407.02K

Frederick M. Hudson
Independent Director
385.02K

Bethany Sensenig
Independent Director
514.39K

Dr. Georges Gemayel,PhD
Independent Director
378.52K

Dr. Carrolee Barlow, M.D.,PhD
Independent Director
376.02K

SUPN Supernus Pharmaceuticals

About Supernus Pharmaceuticals Company

Company Profile

Company Executives

Trending Stocks